References
- The Papyrus Ebers: the greatest Egyptian medical document. Translated by B. Ebbell. Copenhagen, Levin & Munksgaard 1937; 108–13.
- Sylvest E. Epidemic myalgia: Bornholm disease. London, Oxford University Press, 1934.
- Beard G. Neurasthenia, or nervous exhaustion. Bost Med Sur J 1869; 3: 217–221.
- Ramsay A. Epidemic neuromyasthenia: 1955-1978. Postgrad Med J 1978; 54: 718–21.
- Holt GW. Epidemic neuromyasthenia: the sporadic form. Am J Med Sci 1965; 249: 98–112.
- Ramsay AM, O'Sullivan E. Encephalomyelitis simulating poliomyelitis. Lan-cet 1956; 1: 761–64.
- Sumner DW. Further outbreak of a disease resembling poliomyelitis. Lancet 1956; 1: 764–66.
- Ramsay AM. Encephalomyelitis in North West London. A disease simulating poliomyelitis and hysteria. Lancet 1957; 2: 1196–1200.
- Jason LA, Wagner L, Rosenthal S, et al. Estimating the prevalence of chronic fatigue syndrome among nurses. Am J Med 1998; 105(3A): 91S–93S.
- Acheson ED. The clinical syndrome variously called benign myalgic enceph-alomyelitis, Icelandic disease and epidemic neuromyasthenia. Am J Med 1959; 26: 569–95.
- Jellinek JE. Benign encephalomyelitis. Lancet 1956; 2: 494–95.
- Shelokov A, Babel K, Verder E, Welsh W. Epidemic neuromyasthenia: An outbreak of poliomyelitis-like illness in student nurses. N Engl J Med 1957; 257: 345–55.
- Pedersen E. Epidemic vertigo. Brain 1959; 82: 566–80.
- Wright J, Morley DC. Encephalitis tremens. Lancet 1958; 1: 871–73.
- Pellew RAA, Miles JAR. Further investigations on a disease resembling po-liomyelitis seen in Adelaide. Med J Aust 1955; 42: 480–82.
- Sigurdsson B, Gudmundsson KR. Clinical findings six years after the out-break of Akureyri disease. Lancet 1956; 1: 766–67.
- Fukuda K, Strauss SE, Hickie I, et al. The chronic fatigue syndrome: a com-prehensive approach to case definition and study. Ann Intern Med 1994; 121: 953–59.
- Chaudhuri A, Behan WMH, Behan PO. Chronic fatigue syndrome. Proc R Coll Physicians Edinb 1998; 28: 150–63.
- Levine PH, Snow PG, Ranum BA, Paul C, Holmes MJ. Epidemic neuromyas-thenia and chronic fatigue syndrome in West Otago, New Zealand. A 10-year follow up. Arch Int Med 1997; 157: 750–4.
- Chaudhuri A, Behan PO. Overlap syndromes of chronic fatigue. CNS 1(2): 16–20.
- Jamal GA, Hansen S. Electrophysiological studies in the post-viral fatigue syndrome. J Neurol Neurosurg & Psychiat 1985; 48: 691–4.
- Trojan DA, Gendron D, Cashman NR. Anticholinesterase-responsive neuro-muscular junction transmission defects in post-poliomyelitis fatigue. J Neurol Sci 1993; 114: 170–77.
- Bruno RL, Sapolsky R, Zimmerman JR, Frick NM. The pathophysiology of a central cause of post-polio fatigue. Ann NY Acad Sci 1995; 753: 257–75.
- Hilgers A, Frank J, Bolte P. Prolongation of central motor conduction time in chronic fatigue syndrome. J Chronic Fatigue Synd 1998; 4(2): 23–32.
- Samii A, Wassermann EM, Ikoma K et al. Decreased post-exercise facilitation of motor evoked potentials in patients with chronic fatigue syndrome or depression. Neurology 1996; 47(6): 1410–4.
- Kent-Braun JA, Sharma KR, Weiner MW, Massie B, Miller RG. Central basis of muscle fatigue in chronic fatigue syndrome. Neurology 1993; 43: 125–31.
- Behan PO, Behan WHM, Bell EJ. The postviral fatigue syndrome-an analysis of findings in 50 cases. J Infect 1985; 10: 211–22.
- Lane RJ, Barrett MC, Woodrow D et al. Muscle fibre characteristics and lac-tate responses to exercise in chronic fatigue syndrome. J Neurol Neurosurg & Psy-chiat 1998; 64: 362–7.
- McCully KK, Natelson BH, Iotti S, Sisto S, Leigh JS Jr. Reduced oxidative muscle metabolism in chronic fatigue syndrome. Muscle & Nerve 1996; 19: 621–5.
- Barnes PRJ, Taylor DJ, Kemp GJ, Radda GK. Skeletal muscle bioenergetics in the chronic fatigue syndrome. J Neurol Neurosurg & Psychiat 1993; 56: 679–83.
- Wong R, Lopaschuk G, Zhu G et al. Skeletal muscle metabolism in chronic fatigue syndrome. In vivo assessment by 31P nuclear magnetic resonance spectrosco-py. Chest 1992; 102: 1716–22.
- Behan WMH, Holt J, Kay DH, Moonie P. In vitro study of muscle aerobic metabolism in chronic fatigue syndrome. J Chronic Fatigue Synd 1999; 5(1): 3–16.
- Paul L, Wood L, Behan WMH, McLaren WM. Demonstration of delayed re-covery from fatiguing exercise in chronic fatigue syndrome. European J Neurol 1999; 6: 63–9.
- LaManca JJ, Sisto DA, De Luca Jet al. Influence of exhaustive treadmill exer-cise on cognitive functioning in chronic fatigue syndrome. Am J Med 1998; 105(3A): 59S–65S.
- Dowsett EG, Colby J. Long term sickness absence due to ME/CFS in UK schools: an epidemiological study with medical and educational implications. J Chron-ic Fatigue Synd 1997; 3: 29–42.
- Tirelli U, Chierichetti F, Tavio M et al. Brain Positron Emission Tomography (PET) in chronic fatigue syndrome: preliminary data. Am J Med 1998; 105(3A): 54S–58S.
- Patterson J, Aitchison F, Wyper DJ et al. SPECT brain imaging in chronic fa-tigue syndrome. EOS-J Immunol Immunopharmacol 1995; 15: 53–58.
- Goldberg M, Meena I, Darcourt J. NeuroSPECT findings in children with chronic fatigue syndrome. Proceedings AACFS Conference 1994; 79.
- Schwartz RB, Komaroff AL, Garada BM et al. SPECT imaging of the brain: comparison of findings in patients with chronic fatigue syndrome, AIDS dementia complex and major unipolar depression. AJR 1994; 162: 943–51.
- Smith AP, Behan PO, Bell W, Millar K, Bakheit M. Behavioural problems as-sociated with the chronic fatigue syndrome. Br J Psychology 1993; 84: 411–23.
- Christodoulou C, DeLuca J, Lange Get al. Relation between neuropsycholog-ical impairment and functional disability in patients with chronic fatigue syndrome. J Neurol Neurosurg Psychiat 1998; 64: 431–4.
- Prasher D, Smith A, Findley L. Sensory and cognitive-event related potentials in myalgic encephalomyelitis. J Neurol Neurosurg & Psychiat 1990; 53: 247–53.
- Johnson SK, DeLuca J. Selective impairment of auditory processing in chron-ic fatigue syndrome: a comparison with multiple sclerosis and healthy controls. Per-ceptual and Motor Skills 1996; 83: 51–62.
- Deisher JB. Benign myalgic encephalomyelitis (Iceland Disease) in Alaska. Northwest Medicine 1957; 56: 1451–56.
- Sharpley A, Clemens A, Hawton K, Sharpe M. Do patients with "pure" chronic fatigue syndrome (neurasthenia) have abnormal sleep? Psychosomatic Medi-cine 1997; 59: 592–6.
- Fischler B, LeBon 0, Hoffman Get al. Sleep anomalies in the chronic fatigue syndrome. A comorbidity study. Neuropsychobiology 1997; 35: 115–22.
- Bell IR, Miller CS, Schwartz GE. An olfactory-limbic model of multiple chemical sensitivity syndrome: possible relationship to kindling and affective spec-trum disorders. Biol Psychiatry 1991; 32: 218–42.
- Rosenhall U, Johansson G, Orndahl G. Eye motility dysfunction in chronic primary fibromyalgia with dysesthesia. Scand J Rehab Med 1987; 19: 139–45.
- Ash-Bernal R, Wall II C, Komaroff AL et al. Vestibular function test anoma-lies in patients with chronic fatigue syndrome. Acta Otolaryngol 1995; 115: 9–17.
- Boda WI, Natelson BH, Sisto SA, Tapp WN. Gait abnormalities in chronic fatigue syndrome. J Neurol Sci 1995; 131: 156–61.
- Saggini R, Pizzigallo E, Vecchiet J, Macellari V, Giacomozzi C. Alteration of spatial-tempral parameters of gait in chronic fatigue syndrome patients. J Neurol Sci 1998; 154:18–25.
- Cameron J, Capra MF. The basis of the paradoxic disturbance of temperature perception in ciguatera poisoning. J Toxicol 1993; 31: 571–79.
- Bidard JN, Vijverberg HPM, Frelin C. Ciguatoxin is a novel type of Na+ channel toxin. J Biological Chemistry 1984; 259: 8353–57.
- Sisto SA, Tapp W, Drastal S et al. Vagal tone is reduced during paced breath-ing in patients with the chronic fatigue syndrome. Clinical Autonomic Research 1995; 5: 139–43.
- Bou-Holaigh I, Rowe PC, Kan JS, Calkins H. The relationship between neu-rally mediated hypotension and chronic fatigue syndrome. JAMA 1995; 274: 961–67.
- De Becker P, Dendale P, De Meirleir K et al. Autonomic testing in patients with chronic fatigue syndrome. Am J Med 1998; 105(3A): 22S–26S.
- Branchey L, Branchey M, Zucker D, Shaw S, Lieber CS. Association between low plasma tryptophan and blackouts in male alcoholic patients. Alcoholism (NY) 1985; 9: 393–5.
- Weingartner H, Buchsbaum MS, Linnoila M. Zimelidine effects on memory impairments produced by ethanol. Life Sci 1983; 33: 2159–63.
- McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med 1998; 338: 171–79.
- Terman M, Levine SM, Terman JS, Doherty S. Chronic fatigue syndrome and seasonal affective disorder: comorbidity, diagnostic overlap and implications for treatment. Am J Med 1998; 105(3A): 115S–124S.
- Chaudhuri A, Behan PO. Chronic fatigue syndrome is an acquired neurologi-cal channelopathy. Hum Psychopharmacol Clin Exp 1999; 14: 7–17.
- Trojan DA, Collet J-P, Shapiro S, et al. A multi-center, randomized, double-blinded trial of pyridostigmine in postpolio syndrome. Neurology 1999; 63: 1225–33.
- Luthan JA. Epidemic poliomyelitis. Some pathological observations on hu-man material. Arch Pathol 1946; 42: 245–60.
- Adams RD, Victor M, Ropper AH. Principles of Neurology, sixth edition. New York, McGraw Hill 1998; pp 497–507.
- Bruno RL, Frick NM, Creange SJ, et al. Polioencephalitis and the brain fa-tigue generator model of post-viral fatigue syndromes. J Chronic Fatigue Synd 1996; 2: 5–27.
- Nauta HJW. The relationship of basal ganglia to the limbic system. In: Vinken PJ, Bruyn GW(eds). Handbook of Clinical Neurology, vol 49. Amsterdam, Elsevier Science, pp 19–32.